Precision Era to Redefine Treatment, Drive $450B Economic Investment and Change Lives Across Asia Pacific
Navigating the GLP-1 Opportunity In China: Strategic Imperatives For Western Pharma (Subscription requried)
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
China’s Innovative Drug Coverage Initiative: A Glimpse into the Future, But Insurers Face Hurdles
China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline (Subscription required)
China, where obesity levels are low, becomes hotbed for weight loss drug trials (Subscription required)
Mainland Chinese market for weight loss and diabetes drugs to soon be more crowded: report
Intergenerational wealth transfer is major client priority as financial planning firms invest in technology to enhance client experience
Allowing commercial access to UK Biobank and NHS datasets could boost economy by over £10 billion a year, new research reveals
NASC conference highlights animal supplement trends amid federal reorganization, tariff concerns
